Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Withdrawn1
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (33.3%)
N/A2 (66.7%)

Trials by Status

withdrawn133%
completed133%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

The Effect of Higher Protein Dosing in Critically Ill Patients

NCT03160547
unknownnot_applicable

The EFFORT Trial and EFFORT Outcomes Sub-study (EFFORT-Outcomes)

NCT04931940
withdrawnphase_3

The Effect of Higher Protein Dosing in Critically Ill Patients Ultrasound a Sub-study

NCT04242966

Clinical Trials (3)

Showing 3 of 3 trials
NCT03160547Not Applicable

The Effect of Higher Protein Dosing in Critically Ill Patients

Completed
NCT04931940Not Applicable

The EFFORT Trial and EFFORT Outcomes Sub-study (EFFORT-Outcomes)

Unknown
NCT04242966Phase 3

The Effect of Higher Protein Dosing in Critically Ill Patients Ultrasound a Sub-study

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3